Emergent BioSolutions Inc. - FORM 10-Q - EX-10.4

Attached files

file	filename
EX-32 - Emergent BioSolutions Inc.	exhibit32_2.htm
EX-32 - Emergent BioSolutions Inc.	exhibit32_1.htm
EX-31 - Emergent BioSolutions Inc.	exhibit31_2.htm
EX-31 - Emergent BioSolutions Inc.	exhibit31_1.htm
EX-12 - Emergent BioSolutions Inc.	ex12.htm
EX-10.5 - Emergent BioSolutions Inc.	exhibit10_5.htm
EX-10.3 - Emergent BioSolutions Inc.	exhibit10_3.htm
EX-10.2 - Emergent BioSolutions Inc.	exhibit10_2.htm
10-Q - Emergent BioSolutions Inc.	form10-q032018.htm

EXHIBIT 10.4

Confidential Materials omitted and filed separately with the

Securities and Exchange Commission. Double asterisks denote omissions.

AMENDMENT OF SOLICITATION/MODIFICATION OF CONTRACT

1. CONTRACT ID CODE

PAGE OF PAGES

1 2

2. AMENDMENT/MODIFICATION NO.

00011

3. EFFECTIVE DATE

06/20/2018

4. REQUISITION/PURCHASE REQ. NO.

0000HCGE-2018-25835

5. PROJECT NO. (If applicable)

6. ISSUED BY

CODE

2543

7. ADMINISTERED BY (If other than Item 6)

CODE

2543

(Ö)

Centers for Disease Control and Prevention

Office of Acquisition Services (OAS)

2920 Brandywine Rd, RM 3000

Atlanta, GA 30341-5539

Centers for Disease Control and Prevention

Office of Acquisition Services (OAS)

2920 Brandywine Rd, RM 3000

Atlanta, GA 30341-5539

8. NAME AND ADDRESS OF CONTRACTOR (No., street, county, State and ZIP Code)

EMERGENT BIODEFENSE OPERATIONS LANSING LLC

3500 N MARTIN LUTHER KING JR BLVD

LANSING, MI 48906-2933

9A. AMENDMENT OF SOLICITATION NO.

9B. DATED (See Item 11)

10A. MODIFICATION OF CONTRACT/ORDER NO.

200-2017-92634

10B. DATED (See Item 13)

CODE 026489018

FACILITY CODE

12/08/2016

11. THIS ITEM ONLY APPLIES TO AMENDMENTS OF SOLICITATIONS

The above numbered solicitation is amended as set forth in Item 14. The hour and date specified for receipt of Offers is extended, is not extended.

Offers must acknowledge receipt of this amendment prior to the hour and date specified in the solicitation or as amended, by one of the following methods:

(a) By completing Items 8 and 15, and returning copies of the amendment; (b) By acknowledging receipt of this amendment on each copy of the offer

submitted; or (c) By separate letter or telegram which includes a reference to the solicitation and amendment numbers. FAILURE OF YOUR ACKNOWLEGMENT

TO BE RECEIVED AT THE PLACE DESIGNATED FOR THE RECEIPT OF OFFERS PRIOR TO THE HOUR AND DATE SPECIFIED MAY RESULT

IN REJECTION OF YOUR OFFER. If by virtue of this amendment you desire to change an offer already submitted, such change may be made by telegram or letter,

provided each telegram or letter makes reference to the solicitation and this amendment, and is received prior to the opening hour and date specified.

12. ACCOUNTING AND APPROPRIATION DATA (If required)

See Section B

(Ö)

13. THIS ITEM APPLIES ONLY TO MODIFICATIONS OF CONTRACTS/ORDERS,

IT MODIFIES THE CONTRACT/ORDER NO. AS DESCRIBED IN ITEM 14.

ITEM 10A.

A. THIS CHANGE ORDER IS ISSUED PURSUANT TO: (Specify authority) THE CHANGES SET FORTH IN ITEM 14 ARE MADE IN THE CONTRACT ORDER NO. IN

B. THE ABOVE NUMBERED CONTRACT/ORDER IS MODIFIED TO REFLECT THE ADMINISTRATIVE CHANGES (such as changes in paying office, appropriation date, etc.) SET FORTH IN ITEM 14, PURSUANT TO THE AUTHORITY OF FAR 43.103(b).

C. THIS SUPPLEMENTAL AGREEMENT IS ENTERED INTO PURSUANT TO AUTHORITY OF:

52.217-7 Option for Increased Quantity—Separately Priced Line Item.

D. OTHER (Specify type of modification and authority)

E. IMPORTANT: Contractor is not, Xis required to sign this document and return 1 copies to the issuing office.

14. DESCRIPTION OF AMENDMENT/MODIFICATION (Organized by UCF section headings, including solicitation/contract subject matter where feasible.)

This modification is issued to:

1. Correct the line of accounting for SubCLIN 2004

2. Exercise alternate SubCLIN 2005 from Optional CLIN 0002 and buy an additional [**] doses

3. Increase and fund [**] doses on CLIN 2005 in the amount of $[**]

4. Total funding for this contract has increased by $[**] from $[**] to $[**]

All other terms and conditions remain the same.

Except as provided herein, all terms and conditions of the document referenced in Item 9A or 10A, as heretofore changed, remains unchanged and in full force and effect.

15A. NAME AND TITLE OF SIGNER (Type or print)

Michael Mann/Sr. Manager for Commerical Operations

16A. NAME OF CONTRACTING OFFICER

Sherrie N Randall

15B. CONTRACTOR/OFFEROR

_/s/ J. Michael Mann II________________________

(Signature of person authorized to sign)

15C. DATE SIGNED

16B. UNITED STATES OF AMERICA

BY ___/s/ Sherrie N. Randall____________________

(Signature of Contracting Officer)

16C. DATE SIGNED

06/20/2018

NSN 7540-01-152-8070 STANDARD FORM 30 (REV. 10-83)

PREVIOUS EDITION UNUSABLE 30-105 Prescribed by GSA

FAR (48 CFR) 53.243

Section B – Supplies/Services

Option 1 Items:

ITEM

SUPPLIES / SERVICES

QTY / UNIT

UNIT PRICE

EXTENDED PRICE

0002

BioThrax [**] product

[**] upon date of delivery:

[**] product at a unit price of $[**]

Delivery Address: Contractor's Facility

Delivery to be [**] from the date of exercise of option.

[**]Doses

[

**]

[

**]

ITEM	SUPPLIES / SERVICES	QTY / UNIT	UNIT PRICE			EXTENDED PRICE
2004	BioThrax [] product [] upon date of delivery: [] product at a unit price of $[] Delivery Address: Contractor's Facility Delivery to be NLT [**]	[**]Doses	$	[	**]	$	[	**]
Line(s) Of Accounting: 9390AX3 2642 2018 75-18-0943 5623RF1101 $[] 939ZWUX 2642 2018 75-X-0956 5664711101 ($[]

ITEM	SUPPLIES / SERVICES	QTY / UNIT	UNIT PRICE			EXTENDED PRICE
2005	BioThrax [] product [] upon date of delivery: [] product at a unit price of $[] Delivery Address: Contractor's Facility Delivery to be NLT [**]	[**] Doses	$	[	**]	$	[	**]
Line(s) Of Accounting: 9390AX3 2642 2018 75-18-0943 5623RF1101 $[**]

Emergent BioSolutions Inc. - FORM 10-Q - EX-10.4 - August 2, 2018

Attached files

Emergent BioSolutions Inc. Reports